Stifel Financial Corp decreased its holdings in shares of Mylan (NASDAQ:MYL) by 12.2% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 52,197 shares of the company’s stock after selling 7,283 shares during the quarter. Stifel Financial Corp’s holdings in Mylan were worth $1,637,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of MYL. Pzena Investment Management LLC lifted its holdings in Mylan by 84.1% in the 3rd quarter. Pzena Investment Management LLC now owns 22,721,384 shares of the company’s stock worth $712,770,000 after buying an additional 10,381,697 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Mylan by 12.0% in the 2nd quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock worth $1,276,432,000 after buying an additional 3,531,974 shares in the last quarter. BlackRock Inc. lifted its holdings in Mylan by 4.5% in the 2nd quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock worth $1,575,089,000 after buying an additional 1,751,515 shares in the last quarter. Schroder Investment Management Group lifted its holdings in Mylan by 161,445.9% in the 2nd quarter. Schroder Investment Management Group now owns 1,731,772 shares of the company’s stock worth $67,124,000 after buying an additional 1,730,700 shares in the last quarter. Finally, Teachers Advisors LLC lifted its holdings in Mylan by 72.2% in the 2nd quarter. Teachers Advisors LLC now owns 3,346,814 shares of the company’s stock worth $129,923,000 after buying an additional 1,403,273 shares in the last quarter. Institutional investors and hedge funds own 74.90% of the company’s stock.

Shares of Mylan (NASDAQ MYL) opened at $42.05 on Friday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.95 and a current ratio of 1.46. Mylan has a 1 year low of $29.39 and a 1 year high of $45.87. The firm has a market cap of $22,508.87, a PE ratio of 26.12, a P/E/G ratio of 3.12 and a beta of 1.38.

Mylan (NASDAQ:MYL) last announced its quarterly earnings data on Monday, November 6th. The company reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.20 by ($0.10). Mylan had a net margin of 7.28% and a return on equity of 20.63%. The business had revenue of $2.99 billion for the quarter, compared to the consensus estimate of $3.09 billion. During the same period in the prior year, the company earned $1.38 EPS. Mylan’s quarterly revenue was down 2.3% on a year-over-year basis. research analysts expect that Mylan will post 4.56 earnings per share for the current year.

MYL has been the topic of a number of recent analyst reports. BidaskClub upgraded shares of Mylan from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 19th. Guggenheim initiated coverage on shares of Mylan in a research note on Tuesday, December 12th. They issued a “buy” rating and a $59.00 target price on the stock. UBS Group set a $46.00 target price on shares of Mylan and gave the company a “buy” rating in a research note on Monday, December 4th. ValuEngine upgraded shares of Mylan from a “hold” rating to a “buy” rating in a research note on Friday, December 1st. Finally, Cantor Fitzgerald set a $34.00 target price on shares of Mylan and gave the company a “hold” rating in a research note on Thursday, November 30th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Mylan has a consensus rating of “Buy” and a consensus target price of $42.41.

ILLEGAL ACTIVITY WARNING: “Stifel Financial Corp Sells 7,283 Shares of Mylan (MYL)” was first reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://theolympiareport.com/2017/12/24/stifel-financial-corp-sells-7283-shares-of-mylan-myl.html.

Mylan Company Profile

Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.

Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).

Institutional Ownership by Quarter for Mylan (NASDAQ:MYL)

Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.